Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UK.

Roxanne CookseyMuhammad Azizur RahmanJonathan KennedySinead BrophyErnest H S Choy

Published in: Rheumatology advances in practice (2021)

This real-world descriptive study confirms that patients treated with biologics have reduced disability and time off work despite being initiated ∼13 years after the first symptoms and 6 years after diagnosis.

Keyphrases

ankylosing spondylitis
rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cross sectional
multiple sclerosis
disease activity
machine learning
big data
electronic health record
physical activity
systemic lupus erythematosus
deep learning
sleep quality